Articles tagged with Immunology
The study found that irritability was the most common systemic reaction in children under 2 years, followed by fever and fatigue or sleepiness. Maternal vaccination is thought to be a factor in the higher prevalence of reactions after the first dose.
Researchers created a spatial atlas of the developing human thymus, revealing key differences in immune cell development and function. The study's findings could inform new T cell engineering therapies for cancer treatments, autoimmune conditions, and regenerative immune therapies for older adults or those with compromised immune systems.
Researchers at the Hebrew University of Jerusalem developed a Bayesian metamodeling technique to analyze T-cell activation, revealing intricate patterns in early signaling. The study sheds light on the molecular processes behind T-cell activation and has implications for improving treatments for various diseases.
Researchers at University of California - San Francisco designed biological sensors that can ensure engineered cells are activated in tumor environments, making cancer therapies more effective. The new sensors, called SNIPRs, can bind to soluble molecules and alter gene expression, offering a promising approach for targeted therapies.
New treatment combinations and predictive biomarkers hold promise for improving bladder cancer outcomes. The NIAGARA trial showed that combining immune checkpoint inhibitors with chemotherapy can significantly increase two-year survival rates and reduce cancer recurrences.
The new hospital will provide patient-centered care with personalized, compassionate treatment and groundbreaking research. Patients will have access to top specialists and pioneering therapies in cancer treatment.
A new mechanism has been found by which tumor cells escape the immune system, involving a protein called IRGQ. Studies have shown that suppressing IRGQ can trigger a stronger immune response against cancer cells, leading to improved survival rates in liver cancer patients.
A new study reveals that the sleeping sickness parasite hides in tissues and evades antibodies by constantly changing its protective surface coat. This discovery could lead to a better understanding of the immune response to other pathogens, and may pave the way for developing treatments.
Researchers from Osaka University discovered that the GPR31 receptor in gut surveillance cells detects bacterial metabolites and triggers immune responses, which could lead to new drug developments and probiotic treatments. The study also found that these receptors play a key role in the immune response to gut infections in humans.
Researchers have shown that cancer cells can modify their ribosomes to become less visible to the immune system, allowing them to evade detection. This discovery could lead to new cancer therapies by making these cells more visible to the immune system.
A cohort study found no association between maternal COVID-19 exposure and abnormal neurodevelopmental screening results in children aged 24 months. Continued research is needed due to the developing fetal brain's sensitivity to maternal immune activation.
A new review by Dr. Ruyuan Wang and an international team of researchers sheds light on the complex interactions between the innate and adaptive immune systems, highlighting their composition and distinct functions.
Researchers at TUM found that mitochondrial dysfunction in mice leads to chronic intestinal inflammation and changes in the gut microbiome. The study suggests potential new treatments targeting mitochondrial pathways or addressing the connections between the microbiome and mitochondria.
A study of identical twins found that CD8-positive T cells play a key role in the early stages of multiple sclerosis. The researchers discovered that these cells exhibit increased migration ability, promote inflammation and show activation markers, suggesting they are already embarking on their journey to the central nervous system. Th...
Researchers have made breakthroughs in creating nanoparticles that can modify the immune system to accept transplanted organs without compromising it. This new approach has potential implications for treating diabetes, cell therapy, and autoimmune disorders, offering hope for patients who currently face rejection.
Researchers developed a new combined therapy for multiple sclerosis, combining tolerogenic dendritic cells with Dimethyl Fumarate to restore immune balance. The treatment showed promise in preclinical studies, reducing symptoms in mice and potentially offering hope for patients worldwide.
Researchers created the largest atlas of how tumor architecture changes in response to immune checkpoint therapy. The study found that multiple T cells recognize different neoantigens, altering the tumor ecosystem, and challenged prevailing theories on immunotherapy.
A study found that naldemedine reduces constipation in cancer patients taking opioids, improving quality of life and reducing nausea. After 14 days, 64.6% of naldemedine-treated patients showed no signs of constipation compared to 17.0% in the placebo group.
Researchers found that macrophages produce lipid mediators that promote and suppress inflammation in AKI. The study suggests that MAFB regulates the production of pro-resolving LMs, shifting from a pro-inflammatory to a pro-resolving state.
A large study found that women with premature ovarian insufficiency are 2.6 times more likely to have an autoimmune disorder, with some conditions increasing the risk by 26 times. The study suggests a strong link between POI and severe autoimmune diseases, highlighting the need for medical professionals to be aware of this increased risk.
A recent study by Dr. Esteban Ballestar's group identifies an immune cell population that is more effective in responding against cancer cells under hypoxia. Macrophages undergo changes that enhance their ability to trigger an immune response, leading to better patient outcomes in bladder and ovarian cancers.
A large-scale study will enroll 1,000 patients with acute Lyme disease to identify causes of prolonged symptoms. The research team aims to shed light on why some return to good health and others develop debilitating symptoms.
Researchers found that neoself-antigens, presented on MHC-II, induce an immune response and lead to autoimmunity in lupus patients. EBV reactivation increases the presentation of these antigens, triggering T cell activation and autoimmune disease development.
A new study found that vaccination against respiratory syncytial virus (RSV) for adults over 60 can prevent illness, hospitalizations, lost quality of life, and deaths. The vaccines, Arexvy and Abrysvo, have been shown to be cost-effective in reducing healthcare utilization and societal costs.
Researchers have developed user-friendly tools to analyze spatial proteomics data, enabling biologists to understand how cells communicate with each other. The study sheds light on cellular mechanisms behind synaptic partner matching and immune system coordination, paving the way for new discoveries in biology.
Heidelberg researchers describe a new bottom-up approach to engineer precise immune responses using nanotechnology and synthetic biology. This innovative field holds promise for groundbreaking approaches in disease treatment and prevention.
Researchers from Osaka University discovered that Ikaros binds to Foxp3 to inhibit the expression of target genes, including Ifng, in regulatory T cells. This interaction is crucial for maintaining immune homeostasis and preventing autoimmune disorders.
Researchers at UC Santa Barbara discovered that macrophages can be programmed to respond to light, triggering an increase in their appetite and improving the effectiveness of cancer immunotherapies. The findings offer a new way to enhance trained immunity, a type of memory exhibited in the innate immune system.
A study by Aarhus University researchers reveals that the TMEFF1 gene produces a protein blocking herpesvirus entry into nerve cells, explaining why brain infections are rare. This discovery has great perspectives for understanding viral infections and potentially developing new treatments.
A new DNA-powered signal amplification technology called ACE significantly enhances the sensitivity of mass cytometry, enabling the detection of multiple proteins in single cells. This breakthrough allows researchers to investigate complex biological processes and study immune cell functions with unprecedented depth.
A study published in the Journal of Clinical Immunology found alemtuzumab to be safe and effective in treating Asian patients with inborn errors of immunity after allogeneic hematopoietic cell transplantation. The drug was shown to improve overall survival rates, with 94.7% of patients surviving post-transplantation.
Researchers at Stowers Institute for Medical Research have identified the dengue virus genome's use of less efficient codons in its host's machinery to replicate and spread. This discovery has implications for developing novel antiviral treatments and vaccines, as well as understanding the relationship between viruses and their hosts.
A nested case-control study found that completing fecal immunochemical tests lowers overall death risk from colorectal cancer, particularly in the left colon. The association was observed across racial and ethnic groups, supporting its use in population-based screening strategies.
Researchers found that the recent SARS-CoV-2 variants BA.2.86 and JN.1 have only minor changes in immune evasion compared to their predecessor Omicron, contradicting initial public health concerns.
A novel strategy using venetoclax and azacitidine demonstrates significant anti-cancer effect with mild toxicity for relapsed/refractory AML patients. The treatment showed markedly better survival rates after one year compared to a control group, with improved 'graft-versus-leukemia effects' via alterations of immune cells.
A new study reveals that about two percent of the population develop autoantibodies against type 1 interferons, making them more susceptible to severe viral infections. The autoantibodies remain detectable in the blood for life and are associated with a compromised type 1 interferon system.
Researchers at Memorial Sloan Kettering Cancer Center found that the spatial arrangement of three immune cells - dendritic cell, cytotoxic T cell, and helper T cell - is crucial for effective killing of cancer cells. This discovery has immediate therapeutic implications for immunotherapy treatments.
A new cellular immunotherapy approach shrank tumors in several patients with metastatic colon cancer, showing promise for treating other solid cancers. The treatment involved genetically engineered lymphocytes that recognized and attacked specific cancer cells.
A team of researchers has discovered a mechanism by which the liver's immune cells are suppressed in chronic hepatitis B, leading to organ damage. The 'sleep timer' function allows immune cells to weaken their activity over time, preventing them from proliferating excessively and causing further damage.
Researchers have discovered several rare types of helper T cells associated with immune disorders such as multiple sclerosis and rheumatoid arthritis. The study found that genetic variants in bidirectional enhancer DNA are linked to specific immune-mediated diseases, including inflammatory bowel disease.
Researchers at Lund University developed a hybrid antibody that significantly improves immune function despite weaker binding to antigens. The new antibody's longer stem enhances mobility and signaling capacity, leading to better protection against SARS-CoV-2 and streptococcal bacteria.
Researchers found that adding JAK inhibitors to cancer checkpoint inhibitor immunotherapies improves patients' responses in two separate clinical studies. The combination therapy resulted in better clinical responses in patients with metastatic non-small cell lung cancer and those with relapsed or refractory Hodgkin lymphoma.
Researchers used single-cell sequencing technology to study immune responses in healthy adult volunteers exposed to SARS-CoV-2. They discovered unique immune responses associated with resisting sustained viral infection and disease, including activation of specialized mucosal immune cells and a reduction in inflammatory white blood cells.
Researchers at University of Cambridge uncover unified healer army of regulatory T cells that constantly move and repair damaged tissue. This discovery has implications for treating various diseases, including autoimmune disorders and infectious diseases.
Lopatkin's lab will investigate how bacterial metabolism contributes to antibiotic resistance using sophisticated tools and techniques. The research aims to identify drug-resistance mutations that arise in bacteria adapting to different antibiotics and metabolism-altering chemicals.
A new study finds that periods of fasting can reprogram the immune system's natural killer cells to better fight cancer. The research suggests that fasting may help improve immune responses and make immunotherapy more effective by training NK cells to survive in the tumor environment and produce more cytokines.
Researchers develop fully human antibodies that can neutralize the alpha-latrotoxin of the European black widow, a neurotoxin causing severe pain and hypertension. The study uses in vitro methods to create recombinant human antibodies, offering a safer treatment alternative with potential cross-reactive properties.
Scientists studied how microgravity impacts human peripheral blood mononuclear cells and identified potential compounds to counter its effects, including the antioxidant quercetin. The findings have implications for immune aging on Earth and provide a resource for developing countermeasures.
Scientists at Salk Institute discover a molecular mechanism that helps macrophages mount a coordinated response tailored to a specific immune challenge. The discovery reveals new immune system mechanisms that could be targeted with therapeutics to regulate inflammation.
The NADINA trial found that 59% of patients responded well to neoadjuvant immunotherapy before surgery, allowing them to forgo adjuvant treatment. This treatment approach also showed rapid effects, with 95% of patients remaining tumor-free after just six weeks.
This study found that lowering the fecal immunochemical test positivity threshold can achieve comparable sensitivity and specificity to the multitarget stool RNA test without additional testing. The findings are similar to previous observations with multitarget stool DNA testing, suggesting a potentially simpler screening method.
Researchers at University of Turku have discovered a novel RNA that controls the development and function of regulatory T cells. This finding may enable the development of precision medicine treatments for autoimmune diseases and cancer.
Researchers have identified genetic changes that can leave children born with little to no immune defense against infection. The study links mutations in the NUDCD3 gene to Severe Combined Immunodeficiency and Omenn syndrome, rare and life-threatening immunodeficiency disorders.
A new approach to fighting Epstein-Barr virus-related diseases has been discovered by University of Basel researchers. By inhibiting a specific metabolic pathway in infected cells, the risk of downstream disease can be diminished.
A new type of immune cell, MR1T cells, has been found to detect cancer cells through metabolic traces. This discovery opens up new avenues for targeted therapies against various types of cancer. The cells recognize altered metabolism in cancer cells, which produces specific molecules on the surface.
A Cleveland Clinic-led team of scientists discovered that protein VISTA can directly turn off tumor-fighting T-cells during immunotherapy and resist treatment. The interaction between VISTA and a newly discovered inhibitory receptor LRIG1 suppresses T cell replication, survival, and function.
A team of POSTECH and ImmunoBiome has discovered a dietary-derived bacterial strain, IMB001, that induces nutritional immunity and boosts anti-tumor responses. The strain works by skewing tumor-infiltrating macrophages toward an inflammatory phenotype, leading to increased cell death of rapidly multiplying tumor cells.
Four new research papers demonstrate progress in germline-targeting HIV vaccines, which could offer broad protection. The approach involves priming young B cells to produce broadly neutralizing antibodies against HIV, a crucial step towards developing an effective vaccine.
A research team led by Gloria Choi and Jun Huh will investigate how fever improves autism symptoms in an effort to develop therapies that replicate this effect. They plan to explore the molecular mechanisms behind the 'fever effect' and its potential applications for individuals with autism spectrum disorders.
Researchers from Wyss Institute and Harvard University developed a biomaterial vaccine that enhances and sustains lymph node expansion, leading to more effective anti-tumor responses. The vaccine formulation, based on microscale mesoporous silica rods, reprograms antigen-presenting cells to orchestrate complex immune responses.